We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Bioperfectus Partners with FIND to Increase COVID-19 Self-Testing Capacity in Low and Middle-Income Countries

By LabMedica International staff writers
Posted on 15 Mar 2022
Print article
Image: Bioperfectus has partnered with FIND to lift COVID-19 self-testing capacity in LMICs (Photo courtesy of Bioperfectus)
Image: Bioperfectus has partnered with FIND to lift COVID-19 self-testing capacity in LMICs (Photo courtesy of Bioperfectus)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China), a leading in-vitro diagnostics provider for infectious diseases, has partnered with FIND (Geneva, Switzerland), the global alliance for diagnostics, to accelerate the availability of affordable SARS-CoV-2 self-tests in low- and middle-income countries (LMICs).

Bioperfectus is pioneering in the molecular diagnostics market with products ranging from real-time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices. FIND, the global alliance for diagnostics, seeks to ensure equitable access to reliable diagnosis worldwide. FIND connects countries and communities, funders, decision-makers, healthcare providers and developers to spur diagnostic innovation and make testing an integral part of sustainable, resilient health systems. FIND is co-convener of the Access to COVID-19 Tools (ACT) Accelerator diagnostics pillar and a WHO Collaborating Centre for Laboratory Strengthening and Diagnostic Technology Evaluation.

FIND had launched request for proposal (RFP) in March 2021 in the context of the ACT Accelerator diagnostics pillar, which includes strengthening capacity for countries to expand access to COVID-19 testing based on strategies to reach people where they live, work, and seek care, such as community-based testing and self-testing. In response to the open call, Bioperfectus joined the communication and collaboration, with its fast reaction to the COVID-19 pandemic, advanced R&D capacity, affordability and unique design of its ONE-STEP” COVID-19 Self-testing product. Bioperfectus was chosen from over 80 applicants for fulfilling all the criteria, including the test’s technical performance, suitability for self-administration, and affordability for LMICs. The investment is funded by the German Federal Ministry of Education and Research through KfW and other donors through grants to FIND. FIND will supplement this financial investment with technical support and conduct an independent evaluation of the performance and usability of the tests in the settings of intended use. All help is dependent on a series of mutually agreed project milestones being successfully met.

“We Bioperfectus are very honored to cooperate with FIND to offer bioPerfectus COVID-19 Ag Self-test Kit to LMICs and bridge the gap between the LMICs and HICs (High-income countries) in COVID-19 Self-testing,” the company said in a statement.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd. 
FIND 

Gold Supplier
Hematology Workflow Solution
DIFF-Line
New
Silver Supplier
Deepwell Plates
Accumax Deepwell Plates
New
Gold Supplier
D-Dimer Rapid Test
72091
New
Syphilis Rapid Test
ACON Syphilis Rapid Test

Print article

Channels

Clinical Chem.

view channel
Image: By analyzing urine of patients, it is possible to determine their likelihood of death (Photo courtesy of University of Liverpool)

Urine Test Accurately Predicts End of Life for Lung Cancer Patients

Lung cancer continues to be the leading cause of cancer-related deaths for both men and women around the globe. This deadly disease can affect its victims in various ways, such as through tumor growth... Read more

Molecular Diagnostics

view channel
Image: Biomarkers have shown promise for identifying early risk of pancreatic cancer (Photo courtesy of Pexels)

Biomarker-Based Approach Could Identify Early Risk of Pancreatic Cancer

The incidence of pancreatic cancer is increasing, although the cause of its growing prevalence remains unknown. Even if pancreatic cancer is detected in its early stages, it usually spreads cells throughout... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Sampling a single stool using multiple PCR panels can identify more pathogens rapidly (Photo courtesy of Pexels)

PCR Panels for Acute GI Infections Can Lower Costs, Hospitalization and Antibiotic Use

Acute gastroenteritis impacts adults across all age groups and incurs enormous healthcare expenses. Now, a new study comprising 40,000 hospital visits across various geographic locations has revealed that... Read more

Pathology

view channel
Image: QAi Prostate is an advanced AI-powered prostate cancer diagnosis tool for pathologists (Photo courtesy of Qritive)

AI-Powered Prostate Cancer Diagnosis Tool Accurately Identifies and Classifies Tumors

Prostate adenocarcinoma is the most prevalent form of prostate cancer, representing around 90% of all prostate cases, and is also the second most commonly occurring cancer in men, demonstrating a steady... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.